BRCA testing for all Jews? BRCA testing for everyone?

news 2Co-written by PJGH genetic counselors Estie Rose and Chani Wiesman

This week was a very busy and exciting week for us at the Program for Jewish Genetic Health (PJGH)!  Late last week, the New York Times published two articles describing the findings and ramifications of published research conducted by renowned geneticists in the US and Israel. The first article describes a study done by Dr. Ephrat Levy-Lahad at Shaare Zedek hospital, who concluded that ALL Ashkenazi (Eastern European) Jewish individuals should be tested for BRCA mutations—not just those individuals with family histories of breast and/or ovarian cancers. Since about 1 in 40 Ashkenazis will carry a cancer-predisposing BRCA mutation, genetic testing was suggested for everyone at a young age.  Then, in case a mutation is present, it is better to find out at a preventable stage.

The second article quotes the scientist who discovered BRCA’s association with cancer and who partnered on the Israeli study, Dr. Mary –Claire King. Dr. King’s statements took this one step further, as she called for screening all American woman 30 or older regardless of race or ethnic background—not just Ashkenazis!

Our inboxes have been flooded and the phones have been ringing all week with inquires about these articles.  So how do we feel about these statements? If you have been listening to the news, the media made it sound like these are new ‘guidelines’ or ‘recommendations,’ but we prefer the word ‘opinions.’ These opinions come from a good place, where people want to prevent illness, but they are also somewhat controversial and may be considered by some to be extreme.

For starters, we think it is important to take a step back and spell out what’s so important about BRCA in the Jewish community.  After that, we will get to the “PJGH response” to these studies.

We have spoken about BRCA many (many, many!) times in this blog, but we never actually told you why it is related to the Jewish community (our oversight!). BRCA1 and BRCA2 mutations (mistakes in the genes) cause a significantly increased risk for breast and ovarian cancer, as well as some other cancers.  Just like there are certain mutations for other diseases that are more common in the Ashkenazi Jewish population, there are three specific mutations in the BRCA genes that are more commonly found in the Ashkenazi Jewish population. Numerous studies have found that between 1 in 40 and 1 in 100 Ashkenazi Jews will carry one of those three BRCA mutations and are therefore likely at an increased risk for cancer. If someone is Ashkenazi Jewish and has a BRCA mutation, the vast majority of the time, it is one of those three mutations. Furthermore, that 1 in 40 – 1 in 100 carrier frequency holds true regardless of personal or family history of cancer. So if you take any random group of 100 Ashkenazi Jews, 1 or 2 of them is likely to carry a BRCA mutation, even if he/she doesn’t have a personal or family history of cancer.

This is a big deal, and it’s a huge community issue.

So what is our current response?

Genetic testing: A personal decision

right decisionAs a genetic counselor, I often get asked the dreaded question of “what would you do?” It might seem like there is one correct answer when it comes to the decision of whether or not to pursue genetic testing, but in reality, there is not. One’s decision about genetic testing (Should I pursue genetic testing at all? What type of genetic testing? How extensive should the genetic testing be? When should I pursue genetic testing?) is very dependent on one’s personal circumstances, past experiences, and attitudes.

For the past 5 years, I have consistently worked in a prenatal genetic counseling setting, among other specialty areas. Prenatal genetic counseling deals with genetic testing done during pregnancy for a variety of reasons. There are now many prenatal genetic tests which are out there and available to women during pregnancy. As a prenatal genetic counselor, I know the ins and outs of these tests like the back of my hand, have ordered and interpreted these tests for countless women and couples, and for some, I have advocated for the use of these tests, as they can often provide valuable and actionable information.

I am now almost 9 months pregnant, and even with all the knowledge I have about prenatal testing, genetic diseases, and various abnormalities which can be detected during pregnancy, my decision was to forego almost all of the genetic tests which are currently available, and instead, consistently remind myself that most babies are born healthy.

Even when additional genetic carrier screening became available in the middle of my pregnancy, I opted to wait to update my testing, in order to avoid unnecessary stress and anxiety. I will update my carrier screening at an appropriate time for me, which is not in the middle of my pregnancy.

And yet, many of my genetic counseling colleagues (since we obviously all discuss what we would do…) would choose the complete opposite route. They would do extensive prenatal genetic testing, extensive carrier screening, and want to find out as much information as possible about the genetic make-up of their baby.

Which is the “correct” decision? Well, we each make the correct decision for ourselves. Knowing myself, and knowing all of the many genetic testing options out there, the “low tech” route was correct for me. Someone else? Well, that person will need to weigh the options and figure out which route is correct for them. Genetic testing is always a personal decision. Only you can answer the “Do I want to know?”, “Will this information be helpful for me?”, “Is now the right time?”, and “How will I use this information?” types of questions in order to come to the correct answer for you.

Insurance Coverage and Genetic Testing: Part 3

Image courtesy of http://401kcalculator.org

Image courtesy of http://401kcalculator.org

Before I move on to other (and potentially more interesting) topics to blog about, there are just a few more important things related to genetic testing insurance coverage which are worthwhile discussing. Remember that this insurance terminology dictionary should be helpful for other topics which I don’t discuss here.

I’ve mentioned before how expensive genetic testing can be. Depending on the test, and what technology is being used, each separate genetic test could cost up to a few thousand dollars. When multiple genetic tests are being done, this can rapidly add up. Your insurance company knows this and therefore, has very specific criteria which govern when they will cover genetic testing.

This post is mostly about insurance preauthorization (“pre-auth”). This is otherwise known as a prior authorization, precertification, or predetermination. Different insurance companies may have different names for this process, but the gist is usually the same. This is a process that you or your healthcare provider initiates with your insurance company whereby you ask them to determine if they will pay for a specific service (in our case, genetic testing). Often times, your insurance company will require that you go through the preauthorization process before you pursue genetic testing.

So what is involved in a preauthorization? The insurance company will request that you give them a lot of information about the genetic testing which is being done.  They will want the name of the lab which is actually performing your testing, the name of the doctor ordering your testing, and all of the applicable identification numbers, certification numbers, and contact information associated with your doctor, and the genetics lab.

Then, they’ll want to know where the genetic test is being done and exactly which test will be ordered. It is important to understand that when you do a pre-auth, you cannot rely on the insurance agent involved in your case to know about each and every test that exists. Just saying “a genetic test” or even “a genetic test for cystic fibrosis” will not be enough information for them. This is because there may be multiple genetic tests available for cystic fibrosis, each with its own testing methodology and precision (and therefore price!). Each genetic test actually had a code (or sometimes multiple codes) which identifies it to the insurance company and explains to them what exactly is being done. These codes are called CPT codes and you can get the precise CPT codes you need from the lab performing the test.

The next piece of information the insurance company needs is the indication for your testing, which is also provided in the form of a code called an ICD-9 code. ICD-9 codes vary from broad to specific; some examples include “family history of breast cancer” as an indication for BRCA testing and “café au lait spots” as the reason for ordering genetic testing for neurofibromatosis type 1. ICD-9 codes are important to the insurance companies because they are used to determine if the genetic testing is appropriate for you. You (or your doctor) cannot order a genetic test just because you want it done, and expect your insurance to cover it.

Finally, once this preauthorization has been started, your insurance company will want clinical information. This may be in the form of medical records, imaging studies, or pedigrees, or they may request that a letter of medical necessity be submitted by your healthcare provider. A letter of medical necessity is basically a document written by your healthcare provider that explains their argument for why the insurance company should pay for your testing. Often times it not only includes information about your medical history, but also information about how the testing will be helpful for your future care, and specifically what might change in your medical care based on this testing. It might even cite recent medical literature where genetic testing has made a major difference in situations similar to yours.

The insurance preauthorization process can take anywhere from weeks to months, depending on your insurance company. And even if the preauthorization is approved, it is never a guarantee that your testing will be covered. If the preauthorization is “denied” there is often an appeals process that you can go through to try and change their minds.

So you can see that the process is quite complex and time consuming. Physicians and genetic counselors have a lot of experience with pre-auths, so do not be shy to ask for help if you are overwhelmed with the process!

Genetic Testing at Birth-Is it too Early?

 

UntitledI recently saw a 50-something year old man for a cancer genetic counseling session. When we got to the concept that mutations in the BRCA genes may increase someone’s risk to develop breast and/or ovarian cancer, he was amazed. He said to me, “If the technology exists for someone to know his or her genetic risk to develop cancer, and there may be something to do to reduce these risks, wouldn’t it make sense to learn this information when someone is young?”

I was pleased to hear this question since it proved to me that he was really paying attention, and although he didn’t realize it, he touched on an issue which is very timely in the world of genetics and ethics.  The issue of whole genome sequencing (reading through all of someone’s genes to look for variation) is a hot topic in genetics. Currently, the reasons we might order any genetic testing are if there is an underlying medical issue for the individual, a family history of an issue, or if someone is from an ethnic group that has known founder mutations for particular diseases. When we do this sort of testing, we are looking for relevant mutations in one or more genes or chromosomes.

But recently, scientists have introduced the notion of testing the entire genome of all newborns-even those who are seemingly healthy. (Note: I am not talking about the Newborn Screening panel—AKA “heel stick test” or “PKU test”—which is mandatory in the United States, and tests for about 30-55 diseases, depending on the state).  And to make things sound even more exciting, the first baby to ever have his genome sequenced prenatally was born last month in California!

Back in November 2012, Nicole blogged about her discomfort of whole genome testing, as opposed to targeting the genetic testing to the medical issue at hand.  When we do whole genome sequencing, we are going to learn about that person’s traits, carrier status, predispositions to childhood and adult-onset disease,  and we may even diagnose a disease, possibly presymptomatically (ie- before the person even starts exhibiting symptoms). Some might think that all this information is great, since it’s better to know now than to be surprised when it happens.

Others believe that this type of testing for newborns is unethical. Here are a couple of reasons why:

1-The genes belong to the child, not the parents. Shouldn’t it be up to that child to make this decision?

2- Say we learn that the child is genetically predisposed to having Parkinson’s disease. This most likely will not happen for another 50 or so years, and it may never happen at all.  Does he want to be that person who is just waiting to get sick? This may cause anxiety, stigma, and may change the way his family and friends perceives him.

3- If someone learns from a young age that he has a genetic predisposition to a condition, he may ignore the other (non-genetic) risk factors. For example, let’s say someone learns that he has a genetic variant that leads to a high chance of developing diabetes. He may not try to eat healthy foods or exercise or go for checkups because he believes that his genes alone will determine his risk for diabetes. This is what we call “genetic determinism.”

I told my patient that he did not realize that he had opened up a can of worms and that we would need a whole new session just to discuss his question. But he definitely got me thinking.

 

Insurance Coverage and Genetic Testing: Part 2

image courtesy of www.stockmonkeys.com

(image courtesy of http://www.stockmonkeys.com)

“My insurance said that the testing would be covered, so how did I end up getting a bill?”

Although I alluded to some of these issues in a previous post on the subject, I figured it would be worthwhile to spend a bit more time discussing some of the ins and outs related to health insurance coverage for genetic testing and genetic services. A Carnegie Mellon University study published in September 2013 found that 86 percent of Americans between the ages of 25 and 64 didn’t understand the fundamental concepts of any kind of health insurance. While I won’t be explaining all concepts related to health insurance, an insurance terminology dictionary can be helpful if you have additional questions which I don’t address here. And remember, insurance companies tend to have many different plans with different terms, so just because your plan is from Aetna or Cigna, you might have different benefits and financial responsibilities than others who use the same insurance company.

When it comes to your health insurance coverage, even though you pay monthly premiums, (ie. your monthly cost to have health insurance), you may still have other financial responsibilities whenever you receive medical services. Some of the most common financial responsibilities are co-pays, coinsurance, and deductibles.

The co-pay is typically the most understood concept, as it is fairly straightforward. Whenever you have a doctor’s visit or other medical service provided, you pay an amount which was previously set by your insurance company. This is usually somewhere between $10 – $50 depending on your specific policy and the type of services being provided.

However, some insurance companies expect you to pay a certain percentage of each visit cost. This is called a co-insurance, and it is typically represented as a percentage, as in, your co-insurance is 20%, which would mean that when you go to the doctor or have other medical services provided, you are responsible to pay 20% of what those services cost, while your insurance will cover the other 80%. Again, the specific percentage co-insurance that you are responsible for will vary based on your insurance company and plan.

Your deductible is basically the amount of money you need to pay towards your medical care before your insurance starts paying. This is often a very confusing concept for people to understand. So basically, you’ve just paid $500 per month for health insurance (for example) and you go to the doctor’s office, and you get a bill for the full cost of the visit! Isn’t that why you paid all that money for health insurance, so that the health insurance would pay for your doctor visits?? The answer is obviously yes, however, depending on your insurance policy, you may have a deductible and sometimes, they can be very high! If for example your deductible is $2,000, that means that you need to pay out of pocket, for the first $2,000 of your medical care (doctors visits, lab tests, etc). Once you pay that $2,000, then your insurance will start paying for your medical services, under the terms of your plan, ie- you may need to pay the $2,000 towards your own medical care, and then once your deductible is met, since you have a 20% co-insurance, so your insurance company will cover only 80% of the cost of services you receive.

So when you come in for genetic testing, and you call your insurance company to find out if your testing will be covered, they might tell you that the testing is a covered service, as in, yes, your insurance covers it in general, but they aren’t necessarily explaining how much you may be responsible for because of your deductible, co-insurance, and co-pays.  If you have not yet met your deductible, and your deductible is $5,000, you might get a bill for all of the services provided up until $5,000. If you’ve met your deductible, or you don’t have one, but your co-insurance is 30%, you might still get a hefty bill for your genetic testing, because as I explained before, genetic testing is unfortunately very expensive.

If you are having genetic testing (or really any medical services), it is worthwhile to speak to your insurance company and ask them about the specific terms of your plan. Armed with this new knowledge about co-pays, co-insurance, and deductibles, you are now better informed and capable of having a good understanding about your financial responsibility for genetic testing. Trust me, your medical providers do not want you to end up with large and unexpected bills either.

Genetics and Athletics

heart basketballLast week while my husband and I watched the NBA draft, we were touched to see 20 year old Isaiah Austin receive a ceremonial pick by the NBA. Austin is a star center for Baylor’s basketball team and has been projected to be a first round pick in the next NBA draft.  When he went for his routine physical, his electrocardiogram was abnormal, and Austin was sent for a more comprehensive cardiac workup. Soon after, he was diagnosed with the genetic condition known as Marfan syndrome and was advised by his doctors to quit playing competitive basketball.

At 7’1”, Austin’s height makes him an asset to any basketball team, but his height also is telling of his condition. Marfan syndrome is a connective tissue disorder.  Because connective tissue is found throughout the body, Marfan syndrome can affect many different parts of the body, such as the heart, blood vessels, bones, joints, and eyes. The classic “Marfanoid habitus” is someone who is very tall and thin, with long fingers, flexible joints, scoliosis, and a chest that sinks in. Some features of Marfan features, such as aortic enlargement (expansion of the main blood vessel that carries blood away from the heart to the rest of the body), can be life-threatening. So while some signs of Marfan are easy to see, some affected individuals may have the disease and not even know. Those affected individuals are at highest risk to have sudden cardiac death (SCD), since they might not be seeing their doctors or reducing their risks of aortic dissection or lung collapse.

Each year, SCD claims more than 300,000 lives in the United States. Up to 10% of cases of sudden cardiac death in general, and 25% of cases involving a family history, are thought to have a hereditary basis. Aside from Marfan, there are other conditions which can include SCD—some of these conditions include Long QT, Brugada syndrome and hypertrophic cardiomyopathy. Most inherited arrhythmia conditions such as those mentioned have an autosomal dominant inheritance pattern. If someone has it, there is a 50% chance he or she will pass it on to each child.  For many of the SCD diseases, genetic testing can help establish a diagnosis and may serve as a tool to screen family members.  Medications, medical surveillance, and reducing physical activity can save lives. As with Austin, knowing your risk before something devastating happens is key.

Austin was tested for Marfan because he had an abnormal screening test, but most athletes do not engage in genetic testing.  Sports-related genetic testing is not widely used, but is available. While many professional sports organizations have shown interest in having players screened for conditions such as sickle cell disease and hypertrophic cardiomyopathy, GINA issues arise and players’ genetic information is no longer legally accessible to their employers.  Recently, more than a dozen companies have started  to offer sports-related personal genomics tests and services. The “DNAthlete: Athletic Profile” provides consumers with genetic information related to endurance, muscle mass and strength, and grip strength. While the clinical utility of this information is up for debate, many athletes may want this information so they can integrate it into their training regimens.

“I have a whole life ahead of me,” Austin said. “I’m not going to sit here and I’m not going to sulk about not being able to play basketball anymore, because I can still be involved with the game somehow or some way.”

When asked what’s next, Austin responded “Everything.”  And that is exactly why he was the NBA’s most valuable draft pick.

The PJGH goes camping

camp pjgh banner

As a scientist, I am used to running experiments, and, par for the course, oftentimes these experiments fail. I am pleased to blog here about an experiment we ran this past week at Einstein that proved to be a huge success! Specifically, the Program for Jewish Genetic Health (PJGH) ran its first ever Jewish Genetics Bootcamp, and for this endeavor I temporarily changed my role from Program Director to Camp (co-)Director (along with our two amazing PJGH genetic counselors Chani and Estie).

The camp was envisioned as a mechanism to introduce high school and college students who have expressed future career interests in genetics to the field (from the PJGH perspective). While students in this category sometimes intern with us or alternatively are mentored by us in more informal ways, unfortunately we cannot accommodate all requests for this. Camp, or more appropriately bootcamp (keep reading this blog…), was our three-day solution to this problem.

We decided to keep the inaugural group of campers small, since we thought this would facilitate interactions between the campers and the staff. Fortunately, the campers who joined proved to be outgoing, inquisitive, and insightful—which led to lots of questions, discussion, and debate. We even picked up 2 crashers!—undergrads who happened to be on the Einstein campus for summer research programs.

Camp PJGH centered around half-day sessions, presented by Chani and Estie, on three main topics: clinical genetics/genetic testing, Jewish genetic diseases that can affect offspring of carrier couples (e.g., Tay-Sachs and Familial Dysautonomia), and inherited cancer predisposition syndromes (e.g., hereditary breast and ovarian cancer syndrome due to BRCA). Another more future-looking session was entitled “Expanding panels, expanding ancestries, and expanding technologies.”

Aside from these formal sessions, we also exposed the campers to a variety of genetics professionals—a genetic counselor, a PhD scientist, an MD reproductive geneticist, an MD pediatric geneticist, and an MD fertility specialist. The presenters reviewed their training paths, shared what their typical workdays look like, and divulged their most/least favorite aspects of their jobs. The campers were intrigued by the fact that many of us have had “turning points” that have resulted in the refocusing of career paths. For me in particular, my transitions have been from research scientist to clinical laboratory scientific director to PJGH program director. When describing the last transition, I was really able to convey how my journey has led me to a remarkable endpoint where I am able combine my scientific background with the service of the Jewish community.

Finally, during the camp’s self-study sessions, the campers were guided through current newspaper articles that were a little more controversial in nature—addressing questions such as should healthy adults (or even healthy babies!) undergo whole genome sequencing, or should all Ashkenazi Jewish individuals be tested for the common BRCA mutations. And, for night activity (okay, it was really homework), the campers were encouraged to visit selected websites including our very own online learning platform, and also were provided with some on-theme book and movie recommendations.

And the experimental result and conclusions are already in. In the campers’ anonymous post-camp evaluations, camp was deemed a big hit! One camper even remarked “it made me realize how much awareness needs to be raised, and how much I want to be involved with genetics in the future.”

I am looking forward to a reunion with season 1 campers, and to planning for season 2!

P.S. And yes, we most definitely had s’mores. But there were no tents and it wasn’t a sleepover camp (although one camper remarked that next time we run a bootcamp, it should be longer than 3 days!)

 

Insurance Coverage and Genetic Testing: Part 1

(image courtesy of www.stockmonkeys.com)

(image courtesy of www.stockmonkeys.com)

As boring as it may seem, I actually get asked this question ALL THE TIME. Both by patients and also while giving talks in the community. People get very excited about the possibility of using genetic testing in their own lives, but wonder, how affordable is it really?

Here are a few things that I’ve learned over the years, which may help you navigate that big wide world of insurance coverage for genetic testing. (Use this helpful insurance terminology dictionary to help you through the post!)

Most of the time, genetic testing is treated like any other lab test. When the lab bills your insurance company, most of the time the genetic testing is covered the same way other lab tests would be covered. You may be responsible for your co-insurance and deductible. This differs by insurance policy! You should find out what your insurance’s policy is! Now, when your doctor checks your cholesterol, if that test costs $60, even if you are responsible for 30% of the cost, your “out of pocket” charge is not so significant. Genetic testing on average costs anywhere from a few hundred dollars per test, to thousands of dollars per test. So even if your insurance “covers” the testing, your co-insurance or deductible may leave you responsible for a large amount of money.

Now, there are a few exceptions to this:

Exception 1: Your insurance has a policy whereby it does not cover ANY genetic testing.  This is not very common, but some insurance policies state straight out, that they do not cover ANY genetic testing under any circumstances. I have seen these policies before. If you are considering undergoing genetic testing, you should call your insurance company and ask if they have any specific policies about genetic testing. Typically they can direct you to the policy on their website so that you can read through it. Nowadays, as genetic testing becomes more commonplace, more insurance companies are developing genetic testing policies about what they will and will not cover, so it is worthwhile to look into this for your specific insurance plan!

Exception 2: Your insurance will only cover genetic testing if the correct “indication” or “code” is provided. Genetic testing is conducted in a medical model (even if it doesn’t always seem that way!) This means that it is ordered by a medical professional because of a certain indication. So in order for your insurance company to actually agree to covering the genetic test, the correct indication need be provided! For example, if you want to have genetic testing for Marfan syndrome, but you don’t have any of the signs or symptoms of this genetic disease, your insurance company will likely not cover the testing because there is no “indication” for it. For specific tests you may need to meet the “testing criteria” in order for your insurance company to cover the test.

Exception 3: Your insurance will only cover genetic testing if it is done at an “in network lab” Many insurance companies want you to use specific labs when you have your testing done. This may be easy for having your cholesterol checked (as that is a common test) however because genetic tests are unique, there may only be one or two labs in the country who do the testing that you need. So your insurance might cover your testing if it was done at Lab A, but Lab A doesn’t offer that test, it is only offered at Lab Q which is both out of state, and out of your insurance’s network.

Unless you’ve had to muddle through insurance policies and medical bills, a lot of this may seem new to you. The truth is, they don’t even teach us this stuff in school! Insurance issues tend to be one of those things you learn “on the job” as a genetic counselor (and one of the things you keep on learning as the field changes). It is definitely worthwhile for you to research your own health insurance plan’s benefits and your financial responsibilities, so you don’t have any surprises when it comes to your medical bills and insurance coverage.

When Bio Isn’t So Boring

My personal and professional worlds recently collided when I sat with my 9th grade son, Brian, to review for his upcoming Biology exam. The subject was the reproductive system, the stages of pregnancy, and fertility. The chapter ended with infertility issues and in-vitro fertilization (IVF), which allowed me to take his Biology unit one step further and explain to him the amazing technology known as “pre-implantation genetic diagnosis (PGD),” a topic on which my Program for Jewish Genetic Health colleagues frequently educate the Jewish community. At first, probably like most teenagers, he didn’t want to learn any more than what he HAD to know for his exam. But I was able to pique his interest by giving him a real life example of the miracle of PGD.

When Brian was 12 years old, one of his Little League teammates, Cody, had a younger brother named Jack who had Familial Dysautonomia (FD), one of the Jewish genetic diseases. Jack was like the team mascot, always there to cheer on Cody and run around the bases after many games. Cody also had two, twin toddler siblings often running around on the sidelines. While Brian knew that something wasn’t quite right with Jack, he was unaware that a modern day technology – PGD – enabled Cody’s mom to subsequently give birth to healthy twins.

So while reviewing infertility and IVF – and harking back to his previous Genetics unit – I was able to bring his Biology unit to life. I first showed him my MyJewishGeneticHealth.com “work” video of Cody’s mom, talking about how the miracle of PGD enabled her to give birth to two healthy twins and know they would not be born with FD. I then signed in to our full MyJewishGeneticHealth.com lesson to show him real video of how PGD is performed…plucking cells from 3-day old harvested embryos and testing them for disease, before implanting the healthy embryos into the womb. It was a real “Whoa, that’s cool!” moment for him, to see video of this technology at work, and to understand the peace of mind it gave to Cody’s mom and dad when they gave birth to their twins.

It’s often a challenge to make your child understand why the material they are studying in class is worthwhile. By showing Brian how modern day science can truly make an impact and prevent heartache in people’s lives, I was able to interest him in learning more than he needed to know for his exam.

Passover and the Seder: Time to be a Historian

sederPassover is traditionally the holiday of history. In fact, it is a unique time which we are told to actually be historians. The whole point of the Seder is so that we tell over the story of how we and our forefathers were slaves in Egypt, and G-d took us out. The Seder is set up to be multigenerational in that sense. Everyone is involved, grandparents, parents, children, and everyone has their own role.

Perhaps you already see where I’m going with this. Use this opportunity, gathered around with your family, to discuss and share your family medical history! Similar to the Seder, everyone in your family has a role in this, especially those who are already considered the family’s medical history “historians”.

Usually there are one or two individuals in the family who know something about the family’s medical history, but everyone else is typically clueless. I see this on a daily basis when I meet with patients and ask them questions about their family histories. I can rapidly tell the difference between those “historians” who know what medical issues run in their families, and those whose answers consist largely of “I don’t know”.

I didn’t know much about my family medical history until I became a genetic counselor and asked my mother (our family’s medical historian) all of the pertinent questions. My sisters still don’t know a lot, and their answers at a doctor’s visit will likely consist of a lot of “I don’t know”s.

Family medical history is something we all should know! It is the best predictor of future medical issues, and can help your doctors direct your care appropriately.

You can use this family history tool created by the Surgeon General, or these guidelines to learn what questions to ask, and how to take your own family history.

 

Follow

Get every new post delivered to your Inbox.

Join 45 other followers

%d bloggers like this: